Milligan John C.K. IV

Secretary/ CEO Of Subsidiary | President/ Secretary

1 company

Milligan John C.K. IV is a Secretary/ CEO Of Subsidiary at TherapeuticsMD, Inc.. Recent SEC Form 4 filings include 4 buys and 11 sells.

Estimated insider holdings value: $3.5M based on current market prices.

Holdings by Company

TXMDMay 11, 2021

Current Shares1.75M

Value$3.47M

Net Activity-1,907,507

Bought: 169.0KSold: 2.08M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 11, 2021	TXMD Therapeuticsmd, Inc.	Secretary/ CEO Of Subsidiary	Sale+OE	44,252	$1.04	$46,022.08	-2.5%	-8.4%	-93.3%
Oct 25, 2019	TXMD Therapeuticsmd, Inc.	President/ Secretary	Buy	72,000	$2.75	$198,000.00	+4.9%	-	-
Oct 25, 2019	TXMD Therapeuticsmd, Inc.	President/ Secretary	Buy	72,000	$2.75	$198,000.00	+4.9%	-	-
Aug 16, 2019	TXMD Therapeuticsmd, Inc.	President/ Secretary	Buy	10,000	$2.93	$29,300.00	+0.3%	-	-
Aug 12, 2019	TXMD Therapeuticsmd, Inc.	President/ Secretary	Buy	15,000	$3.16	$47,400.00	+0.4%	-	-
Dec 18, 2018	TXMD Therapeuticsmd, Inc.	President/ Secretary	Sale+OE	258,127	$3.69	$953,384.90	-8.1%	-	-
Dec 6, 2018	TXMD Therapeuticsmd, Inc.	President/ Secretary	Sale+OE	258,000	$4.77	$1,231,692.00	-8.1%	-	-
Nov 29, 2018	TXMD Therapeuticsmd, Inc.	President/ Secretary	Sale+OE	258,128	$4.96	$1,280,324.35	-8.1%	-	-
Nov 15, 2018	TXMD Therapeuticsmd, Inc.	President/ Secretary	Sale+OE	258,000	$4.90	$1,265,232.00	-8.1%	-	-
Oct 24, 2018	TXMD Therapeuticsmd, Inc.	President/ Secretary	Sale+OE	250,000	$5.35	$1,337,500.00	-7.8%	-	-